The IDEXX water division is committed to protecting public health through a number of innovative technologies which can identify microbiological contamination more quickly and more accurately than traditional methods.
The company, headquartered in Maine USA, helps to protect water quality for an estimated two billion people every day, with tests accepted or approved in more than 40 countries around the world. The test portfolio includes products that identify the presence of coliforms and E.coli, enterococci and opportunistic pathogens such as Pseudomonas aeruginosa, Cryptosporidium and Giardia.
For the European and Middle Eastern regions, the water division’s base is in Newmarket, Suffolk, where pioneering R&D work is undertaken as well as the manufacturing of some of the company’s testing products. It is also the hub for customer and technical support, marketing, quality, administration and general management.
Following extensive independent testing to ensure compliance with the requirements of the HTM 04-01 addendum guidelines, IDEXX launched the Pseudalert® test into the UK healthcare sector, to facilitate the rapid identification of Pseudomonas aeruginosa in hospital water systems. The test gives either a presence/absence, or quantified result, within 24 hours which is less than half the time taken by traditional membrane filtration (agar based) methods. Preparation of the sample takes less than 1 minute of hands-on time and the presence of P. aeruginosa is determined by subsequent fluorescence of the sample following incubation.
The ease and simplicity of the IDEXX tests mean that they can be very easily adopted by contract microbiology laboratories, or performed by trained operatives in environments where the use of a laboratory may be impractical. For this reason, IDEXX tests are used routinely in environments such as ships and oil rigs to monitor water quality.
Pseudalert was the winner of the prestigious IHEEM “Product Innovation in Healthcare” in 2014 and was ‘Highly Commended’ in the Building Better Healthcare awards in 2015.
Since its launch, Pseudalert has been successfully trialled in a number of UK hospitals, and has been adopted by a number of UKAS accredited laboratories which undertake testing in accordance to hospitals’ individual water safety management procedures.
For hospitals where infection can spread rapidly, the need to identify problems, isolate and remediate against possible devastating consequences is crucial. It is for these reasons that IDEXX leads the world in rapid and reliable microbiological testing solutions and continues to pioneer research in new areas to ensure clean and safe water can be maintained.